Fig. 4From: Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & IIDecreasing trend of LDH level in the treated group within 10 days of starting treatment. A significant decrease in LDH levels was observed 10 days post-treatment (P < 0.001)Back to article page